AJMC® in the Press, May 17, 2024

From Niche to Mainstream: Transforming Physical Therapy by Refining Remote Therapeutic Monitoring

CMS introduced the GENEROUS Model to reduce Medicaid drug costs, enhance access, and improve health outcomes for beneficiaries starting in 2026.

November 4th 2025

Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices

Medbridge is working to refine remote therapeutic monitoring, or RTM, to transform physical therapy and enhance patient care.

Listen

The new agreeement establishes reduced pricing for weight loss medications under Medicare and Medicaid or purchased directly through TrumpRX. | Image credit: Fernanda - stock.adobe.com

The White House announced significant drug pricing cuts for GLP-1s for diabetes and obesity for Medicare and Medicaid beneficiaries and on TrumpRx.

Age-Related Disparities in ADC Treatment Rates in Breast Cancer: Tabby Khan, MD

October 31st 2025

Immune Checkpoint Inhibitors Safe to Use for NSCLC in Patients With HIV

A new analysis from Komodo Health pinpointed significant disparities by age and insurance in antibody-drug conjugate (ADC) treatment rates for metastatic breast cancer.

Listen

Lungs | Image credit: magicmine - stock.adobe.com

Phase 3 Study to Evaluate Remibrutinib in Generalized Myasthenia Gravis

The efficacy of immune checkpoint inhibitors was found in patients with both HIV and non–small cell lung cancer (NSCLC), though more inclusion of people with HIV is needed in future studies.

Myasthenia gravis diagnosis | Image Credit: © syahrir-stock.adobe.com

CMS Announces GENEROUS Model to Lower Medicaid Drug Prices

Remibrutinib shows promise in treating generalized myasthenia gravis, with ongoing trials assessing its efficacy and safety for patients.

Related Content

From Niche to Mainstream: Transforming Physical Therapy by Refining Remote Therapeutic Monitoring

CMS introduced the GENEROUS Model to reduce Medicaid drug costs, enhance access, and improve health outcomes for beneficiaries starting in 2026.

November 4th 2025

Trump Announces Deals With Lilly, Novo to Cut Weight Loss Drug Prices

Medbridge is working to refine remote therapeutic monitoring, or RTM, to transform physical therapy and enhance patient care.

Listen

The White House announced significant drug pricing cuts for GLP-1s for diabetes and obesity for Medicare and Medicaid beneficiaries and on TrumpRx.

October 31st 2025

Immune Checkpoint Inhibitors Safe to Use for NSCLC in Patients With HIV

A new analysis from Komodo Health pinpointed significant disparities by age and insurance in antibody-drug conjugate (ADC) treatment rates for metastatic breast cancer.

Listen

Phase 3 Study to Evaluate Remibrutinib in Generalized Myasthenia Gravis

The efficacy of immune checkpoint inhibitors was found in patients with both HIV and non–small cell lung cancer (NSCLC), though more inclusion of people with HIV is needed in future studies.